Lake Street Advisors Group’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Lake Street Advisors Group's EW Position: Q4 2024 in Review
Lake Street Advisors Group increased its Edwards Lifesciences (EW) stake by 18% in Q4 2024, buying an estimated $38.6K and bringing the position to 3,661 shares worth $271K. The position accounts for 0.01% of the portfolio, ranked #480.
Lake Street Advisors Group first reported a position in EW in Q4 2017 and has held it in 17 quarters since. The position peaked at $496K in Q2 2021. 1,227 funds tracked by Wall St. Rank hold EW as of Q4 2024.
- Lake Street Advisors Group held 3,661 shares of Edwards Lifesciences worth $271K as of Q4 2024.
- Lake Street Advisors Group bought 552 Edwards Lifesciences shares in Q4 2024, an estimated $38.6K.
- Edwards Lifesciences made up 0.01% of Lake Street Advisors Group's portfolio in Q4 2024, its #480 holding.
- Lake Street Advisors Group first reported a position in Edwards Lifesciences in Q4 2017 and has held it in 17 quarters since.
- Lake Street Advisors Group's Edwards Lifesciences position peaked at $496K in Q2 2021.
- 1,227 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2024.
Based on Lake Street Advisors Group's 13F filing for Q4 2024, filed 4 Feb 2025.